Get the Stockscreener App
5.1886
5.03%
0.1186
Genelux Corp stock is traded at $5.1886, with a volume of 50,106.
It is up +5.03% in the last 24 hours and up +34.81% over the past month.
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
See More
Previous Close:
$5.07
Open:
$5.01
24h Volume:
50,106
Relative Volume:
0.38
Market Cap:
$201.14M
Revenue:
-
Net Income/Loss:
$-27.66M
P/E Ratio:
-5.4617
EPS:
-0.95
Net Cash Flow:
$-24.36M
1W Performance:
+17.29%
1M Performance:
+34.81%
6M Performance:
+116.46%
1Y Performance:
+104.02%
1-Day Range:
$5.01
$5.47
1-Week Range:
$4.51
$5.7231
52-Week Range:
$1.9875
$5.885
Genelux Corp Stock (GNLX) Company Profile
Name
Genelux Corp
Sector
Industry
Phone
805-267-9889
Address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Compare GNLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
5.325 | 191.51M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-24 | Initiated | Guggenheim | Buy |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Nov-27-23 | Initiated | H.C. Wainwright | Buy |
| Sep-12-23 | Initiated | Maxim Group | Buy |
| Feb-15-23 | Initiated | The Benchmark Company | Speculative Buy |
Genelux Corp Stock (GNLX) Latest News
What’s next for Genelux Corporation stock priceTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Genelux (NASDAQ:GNLX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Applying chart zones and confluence areas to Genelux CorporationWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Yahoo Finance
Can Genelux Corporation stock outperform in 2025 bull market2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Market reaction to Genelux Corporation’s recent newsTrade Ideas & Long-Term Investment Growth Plans - newser.com
How Genelux Corporation stock performs in rate cut cyclesJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 04:03:28 - newser.com
Genelux Corporation $GNLX Shares Bought by Woodward Diversified Capital LLC - MarketBeat
Is Genelux Corporation stock a buy before product launches2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Is this a good reentry point in Genelux CorporationJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Goldman Sachs Group Inc. Buys Shares of 88,463 Genelux Corporation $GNLX - Defense World
Will Genelux Corporation continue its uptrendJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
What drives Genelux Corporation stock priceStop Loss Placement Tips & Achieve Consistent Profits - earlytimes.in
Will Upcoming Readouts Push Genelux Toward A Broader Therapeutic Role? - RTTNews
Real time scanner hits for Genelux Corporation explainedRate Cut & Weekly High Potential Stock Alerts - newser.com
Whale Trades: Is Genelux Corporation showing insider buying2025 Earnings Surprises & Weekly High Return Stock Opportunities - خودرو بانک
Relative strength of Genelux Corporation in sector analysisJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Tick level data insight on Genelux Corporation volatilityMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Retail Trends: Does Genelux Corporation stock reflect fundamentals2025 Retail Activity & AI Driven Stock Reports - khodrobank.com
Analyzing Genelux Corporation with multi timeframe chartsGap Up & Real-Time Buy Signal Alerts - newser.com
Real time pattern detection on Genelux Corporation stockChart Signals & AI Enhanced Market Trend Forecasts - newser.com
Key metrics from Genelux Corporation’s quarterly dataWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Ranking Genelux Corporation among high performing stocks via toolsJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
How to read the order book for Genelux CorporationFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Pullback Watch: Is Genelux Corporation a cyclical or defensive stockGold Moves & Risk Managed Investment Entry Signals - khodrobank.com
Bull Bear: Is Perspective Therapeutics Inc part of any major index2025 Short Interest & Risk Controlled Stock Pick Alerts - خودرو بانک
Is Genelux Corporation stock reversal real or fakeJobs Report & Expert Curated Trade Setups - newser.com
Aug Closing: Is Genelux Corporation trading at a discountJobs Report & Verified Momentum Stock Alerts - khodrobank.com
Measuring Genelux Corporation’s beta against major indicesMarket Risk Analysis & AI Driven Price Predictions - newser.com
Genelux Corporation’s volatility index tracking explainedWeekly Stock Recap & AI Driven Price Predictions - newser.com
Key resistance and support levels for Genelux CorporationWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-09-16 21:46:32 - newser.com
Can you recover from losses in Genelux CorporationMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
Technical Analysis: Can Enlightify Inc stock outperform in a bear marketJuly 2025 Macro Moves & Fast Momentum Stock Entry Tips - خودرو بانک
Real time breakdown of Genelux Corporation stock performanceQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Genelux Corp Stock (GNLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genelux Corp Stock (GNLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zindrick Thomas | President and CEO |
May 12 '25 |
Sale |
2.92 |
10,764 |
31,431 |
191,447 |
| Yu Yong | VP, Clinical Trial Operations |
May 12 '25 |
Sale |
2.92 |
5,579 |
16,291 |
47,640 |
| Cappello Joseph | VP, Pharmaceutical Development |
May 12 '25 |
Sale |
2.92 |
4,737 |
13,832 |
52,266 |
| Smalling Ralph | Head of Regulatory |
May 12 '25 |
Sale |
2.92 |
1,259 |
3,676 |
34,760 |
| Tyree James L | Director |
Dec 30 '24 |
Sale |
2.46 |
3,460 |
8,512 |
45,791 |
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):